跳至主要内容
临床试验/ISRCTN16416766
ISRCTN16416766进行中(未招募)4 期

Carboprost vs Oxytocin as the First Line Treatment of Primary Postpartum Haemorrhage: A phase IV, double-blind, double-dummy, randomised controlled trial.

niversity of Liverpool0 个研究点目标入组 3,948 人开始时间: 2018年10月18日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
3,948

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. =16 years of age
  • 2. Requirement for medical treatment for primary PPH

排除标准

  • 1. Known to have opted out of participation antenatally
  • 2. Known oxytocin or carboprost hypersensitivity
  • 3. Known active cardiac or pulmonary disease
  • 4. Known to have previously been treated as part of COPE
  • 5. Has already received uterotonic drug treatment for postpartum haemorrhage (this does not include PPH prophylaxis)
  • 6. Stillbirth

研究者

发起方
niversity of Liverpool

相似试验